Wednesday, February 10, 2010, 7:48am EST - Canadian Markets open in 1 hour and 42 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

American Oriental Bioengineering Inc. (AOB)

On Feb 9: 4.13 USD   0.00 (0.00%)  
MORE ON AOB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
AMERICAN ORIENTL BIO (NYSE:AOB) Delayed quote dataEdit
Last Trade: 4.13 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 4.13
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 17.20
Day's Range: N/A - N/A
52wk Range: 3.29 - 6.38
Volume: 0
Avg Vol (3m): 1,007,690
Market Cap: 323.47M
P/E (ttm): 7.25
EPS (ttm): 0.57
Div & Yield: N/A (N/A%)
American Oriental Bioengineering Inc. (AOB)
1d  5d  3m  6m  1y  2y  5y  max 
 Add AOB to Portfolio   Download Data

HEADLINES
5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
at Motley Fool (Tue 9:44am)
AMERICAN ORIENTAL BIOENGINEERING INC Financials
EDGAR Online Financials (Sat, Feb 6)
5-Star Stocks Poised to Pop: Res-Care
at Motley Fool (Fri, Jan 29)
The Next Great Place to Invest
at Motley Fool (Fri, Jan 29)
American Oriental Bioengineering - A Value Investment
at Seeking Alpha (Fri, Jan 29)
Five Potential '10-Baggers' for Under $10
RealMoney by TheStreet.com (Wed, Jan 27)
China Aoxing Pharmaceutical Company Announces Successful Completion of Phase III Registration Clinical Study of Tilidine for Moderate to Severe Pain
Marketwire (Mon, Jan 25)
9 Value Stocks Worth Considering Now
at Seeking Alpha (Fri, Jan 22)
China Aoxing Pharmaceutical Company Announces Appointment of New Chief Financial Officer
Marketwire (Wed, Jan 20)
These 5 Underdogs Are No Dogs
at Motley Fool (Wed, Jan 13)
4-Star Stocks Poised to Pop: Universal Travel
at Motley Fool (Wed, Jan 13)
5-Star Stocks on the Upswing
at Motley Fool (Tue, Jan 12)
More Headlines for AOB...

ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.4
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
American Oriental Bioengineering, Inc., together with its subsidiaries, engages in the development, manufacture, and commercialization of plant-based pharmaceutical (PBP) and plant-based nutraceutical (PBN) products.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices